Price
Target price
€41.00
€41.00
-5.090%
-2.2
-5.090%
€49.07
27.09.24 / Tradegate
WKN: A1W2RM / Symbol: AGIO / Name: Agios / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Agios Pharmaceuticals Inc. Stock
Agios Pharmaceuticals Inc. took a tumble today and lost -€2.200 (-5.090%).
We see a rather positive sentiment for Agios Pharmaceuticals Inc. with 11 Buy predictions and 1 Sell predictions.
With a target price of 49 € there is a slightly positive potential of 19.51% for Agios Pharmaceuticals Inc. compared to the current price of 41.0 €.
So far the community has only identified positive things for Agios Pharmaceuticals Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Agios Pharmaceuticals Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
C******** o* t** e**********
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Agios Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Agios Pharmaceuticals Inc. | -5.090% | -3.756% | -0.485% | 75.214% | 99.029% | -0.582% | 31.495% |
| Ironwood Pharmaceuticals | 1.120% | -6.250% | -17.431% | -59.322% | -64.706% | -68.696% | -54.082% |
| Arrowhead Pharmaceuticals Inc. | 0.280% | -5.395% | -20.429% | -28.989% | -37.411% | -68.572% | -28.455% |
| Novocure Ltd | 3.320% | -11.972% | -13.230% | -13.632% | -2.137% | -87.005% | -79.193% |
Comments
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Show more
Ratings data for AGIO provided by MarketBeat
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $55.00 price target on the stock.
Show more
Ratings data for AGIO provided by MarketBeat
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its price target raised by analysts at Royal Bank of Canada from $53.00 to $55.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for AGIO provided by MarketBeat